{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-030623","form_type":"8-K","ticker":"OCGN","cik":"0001372299","company_name":"Ocugen, Inc.","filed_at":"2022-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.188464+00:00","generated_at":"2026-06-27T01:28:56.990575+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ocugen: FDA declines to issue EUA for COVAXIN in pediatric population (ages 2-18)","bullets":["CFO Sanjay Subramanian resigns effective March 18, 2022; no disagreement with company.","Board appoints Jessica Crespo (VP Corporate Controller) as Chief Accounting Officer and SVP Finance.","FDA declined to issue Emergency Use Authorization for COVAXIN for ages 2-18.","Ocugen intends to continue working with FDA to evaluate regulatory pathway for pediatric use."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-030623","json":"https://secwatch.observer/filing/0001104659-22-030623.json","markdown":"https://secwatch.observer/filing/0001104659-22-030623.md","text":"https://secwatch.observer/filing/0001104659-22-030623.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372299/000110465922030623/0001104659-22-030623-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372299/000110465922030623/tm228454d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T01:28:56.990575+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8c2c7ef761","claim":"Sanjay S. Subramanian resigned as Chief Financial Officer at Ocugen, Inc..","evidence_excerpt":"On March 2, 2022, Sanjay S. Subramanian, Chief Financial Officer and Head of Corporate Development of Ocugen, Inc. (the “Company”), tendered his resignation to the Company, effective as of March 18, 2022 (the “Effective Date”), in order to pursue new opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372299/000110465922030623/0001104659-22-030623-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"d7f6822ecc","claim":"Jessica Crespo was appointed as Chief Accounting Officer and Senior Vice President, Finance at Ocugen, Inc..","evidence_excerpt":"On March 4, 2022, the Board appointed Jessica Crespo, the Company’s Vice President, Corporate Controller & Treasurer, to Chief Accounting Officer and Senior Vice President, Finance, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372299/000110465922030623/0001104659-22-030623-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Accounting Officer and Senior Vice President, Finance"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}